Viewing Study NCT06997068


Ignite Creation Date: 2025-12-24 @ 5:55 PM
Ignite Modification Date: 2026-02-22 @ 5:09 PM
Study NCT ID: NCT06997068
Status: RECRUITING
Last Update Posted: 2025-07-14
First Post: 2025-05-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Oral Cavity Cancer in a Rural Midwest United States Population
Sponsor: Mayo Clinic
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module